BME Frontiers,
Journal Year:
2024,
Volume and Issue:
5
Published: Jan. 1, 2024
Deep-tissue
solid
cancer
treatment
has
a
poor
prognosis,
resulting
in
very
low
5-year
patient
survival
rate.
The
primary
challenges
facing
tumor
therapies
are
accessibility,
incomplete
surgical
removal
of
tissue,
the
resistance
hypoxic
and
heterogeneous
microenvironment
to
chemotherapy
radiation,
suffering
caused
by
off-target
toxicities.
Here,
sonodynamic
therapy
(SDT)
is
an
evolving
therapeutic
approach
that
uses
low-intensity
ultrasound
target
deep-tissue
tumors.
ability
deliver
energy
safely
precisely
into
small
(>10
cm)
volumes
makes
SDT
more
effective
than
conventional
photodynamic
therapy.
While
currently
phase
1/2
clinical
trials
for
glioblastoma
multiforme,
its
use
other
treatments,
such
as
breast,
pancreatic,
liver,
prostate
cancer,
still
preclinical
stage,
with
further
investigation
required
improve
efficacy.
This
review,
therefore,
focuses
on
recent
advances
treatments.
We
describe
interaction
between
sonosensitizer
molecules
associated
transfer
mechanism
malignant
cells,
which
plays
central
role
SDT-mediated
cell
death.
Different
sensitizers
used
various
treatments
listed,
critical
parameters
reviewed.
also
discuss
approaches
efficacies
these
sonosensitizers,
3-dimensional
spheroid
vitro
investigations,
ultrasound-controlled
CAR-T
SDT-based
multimodal
therapy,
machine
learning
optimization,
could
facilitate
translation
SDT.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(38)
Published: April 27, 2024
Abstract
Antibacterial
photodynamic
therapy
(aPDT)
and
antibacterial
sonodynamic
(aSDT)
utilize
sensitizers
(photosensitizers/sonosensitizers)
to
produce
reactive
oxygen
species
(ROS)
for
treatment
under
the
stimulation
of
light/ultrasound,
which
have
characteristics
broad‐spectrum
properties,
low
drug‐resistance,
effective
targeting
infected
tissues.
Nanomaterials
in
aPDT/aSDT
are
primarily
used
as
nano‐sensitizers
or
nano‐carriers
sensitizers.
They
enhance
stability
permeability
sensitizers,
improve
strengthen
photodynamic/sonodynamic
properties
(modification
absorption
efficiency
light/ultrasonic
response
stress
by
modulation
nanoparticle
shape,
size,
structure).
Also,
they
modifiability
(controlling
release
rate
time
sensitizer
needed
optimize
therapeutic
effect),
programmability
multifunctionality
(flexible
application
nanotechnology
designing
with
multiple
functions,
such
drug
delivery,
targeted
therapy,
monitoring),
expand
possibilities
combination
therapies
(the
can
be
loaded
other
agents,
enabling
therapies).
expected
further
promote
development
achieve
improved
effects.
This
review
summarizes
progress
nanomaterials
recent
years
based
on
current
strategies
provide
a
theoretical
reference
aPDT/aSDT.
ACS Applied Nano Materials,
Journal Year:
2024,
Volume and Issue:
7(4), P. 4441 - 4452
Published: Feb. 7, 2024
Sonodynamic
therapy
(SDT)
is
a
promising
ultrasound
(US)-triggered
therapeutic
modality
for
anticancer
treatments
due
to
its
high
penetration,
safety,
and
noninvasiveness.
Its
efficiency
closely
related
the
performance
of
sonosensitizers
oxygen
concentration
tumor
microenvironment
(TME).
Herein,
inspired
by
adhesion
cocklebur,
rough-surface
sonosensitizer
gold
platinum
encapsulated
with
magnesium
silicate
loaded
glucose
oxidase
(AuPt@MgSiO3@GOx,
APMS-GOx)
an
enzymatic
cascade
activity
was
designed
improve
delivery
capability,
produce
reactive
species,
reduce
in
tissue.
The
rough
surface
APMS-GOx
can
ability
nanomaterials
deliver
areas.
reaction
induce
starvation
level
oxygen.
Adequate
not
only
alleviate
hypoxia
TME
but
also
further
convert
singlet
(1O2)
under
US
activation.
Moreover,
GOx
increases
involvement
US,
resulting
positive
effect
on
therapy.
Furthermore,
exhibits
near-infrared
absorption
properties,
providing
photoacoustic
imaging-guided
combination
breast
strategy.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(4), P. 792 - 792
Published: Feb. 15, 2024
Fluorescein-mediated
sonodynamic
therapy
(FL-SDT)
is
an
extremely
promising
approach
for
glioma
treatment,
resulting
from
the
combination
of
low-intensity
focused
ultrasound
(FUS)
with
a
sonosensitizer.
In
present
study,
we
evaluated
efficacy
and
immunomodulation
SDT
fluorescein
as
sonosensitizer
in
immunocompetent
GL261
mice
first
time.
vitro
studies
demonstrated
that
exposure
cells
to
FL-SDT
induced
immunogenic
cell
death
relevant
upregulation
MHC
class
I,
CD80
CD86
expression.
vivo
were
then
performed
treat
glioma-bearing
FL-SDT,
alone,
or
FUS
alone.
Perturbation
glioma-associated
macrophage
subset
within
immune
microenvironment
was
by
all
treatments.
Notably,
depletion
myeloid-derived
suppressor
(MDSCs)
concomitant
robust
infiltration
CD8+
T
observed
SDT-FL-treated
mice,
significant
radiological
delay
progression
consequent
improvement
survival.
Tumor
control
improved
survival
also
treated
FL
alone
(median
41.5
days,
p
>
0.0001
compared
untreated
mice),
reflecting
considerable
modulation
microenvironment.
Interestingly,
high
circulating
lymphocyte-to-monocyte
ratio
very
low
proportion
MDSCs
predictive
better
FL-
FL-SDT-treated
than
FUS-treated
which
elevated
monocyte
MDSC
frequencies
correlated
worse
The
immunostimulatory
potential
treatment
profound
most
immunosuppressive
components
encouraged
exploration
immunotherapeutic
strategies.
Small Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 11, 2025
Cancer
is
a
daunting
global
health
problem
with
steadily
rising
incidence.
Despite
the
wide
arsenal
of
current
anticancer
therapies,
challenges
such
as
drug
resistance,
tumor
heterogeneity,
poor
targeting,
and
severe
side
effects
often
lead
to
suboptimal
efficacy
patient
outcomes,
highlighting
need
for
innovative
therapies.
Autophagy
modulation
has
emerged
an
attractive
approach
complement
existing
The
dual
role
autophagy
in
cancer
promotion
suppression
inspired
development
new
drugs
therapeutic
strategies
focusing
on
both
inhibition
induction.
promising
results
modulators
preclinical
studies,
lack
selectivity
potency,
toxicity,
pharmacokinetics,
inadequate
targeting
continue
limit
their
successful
clinical
translation.
Many
these
could
be
overcome
using
nanomedicine.
This
review
explores
recent
advancements
nanomedicine
modulation.
Successful
combination
leveraging
nanoparticles
synergy
chemotherapy,
immunotherapy,
phototherapy,
gene
therapy,
other
modalities
are
presented.
Additionally,
nanomaterials
intrinsic
autophagy‐modulating
capabilities,
self‐assembling
inhibitors,
discussed.
Finally,
limitations
currently
trials
discussed,
future
perspectives
designing
implementation
explored.